Company Valuation: COSMOS Pharmaceutical Corporation

Data adjusted to current consolidation scope
Fiscal Period: May 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 6,03,094 4,83,107 5,25,081 5,02,890 7,00,001 5,05,899 - -
Change - -19.9% 8.69% -4.23% 39.2% -27.73% - -
Enterprise Value (EV) 1 5,53,560 4,50,132 4,97,354 4,77,918 6,92,920 4,85,619 4,80,298 4,77,570
Change - -18.68% 10.49% -3.91% 44.99% -29.92% -1.1% -0.57%
P/E 22.2x 20.9x 22.1x 20.6x 22.6x 14.9x 15.7x 14.8x
PBR 3.54x 2.54x 2.49x 2.17x 2.72x 1.68x 1.64x 1.49x
PEG - -1.4x 7.98x 7.61x 0.8x 4.32x 12.74x 2.43x
Capitalization / Revenue 0.83x 0.64x 0.63x 0.52x 0.69x 0.43x 0.43x 0.4x
EV / Revenue 0.76x 0.6x 0.6x 0.5x 0.69x 0.44x 0.4x 0.38x
EV / EBITDA 11.8x 10x 10.5x 9.29x 11.1x 7.32x 6.88x 6.42x
EV / EBIT 16.7x 15.1x 16.5x 15.2x 17.1x 11.5x 10.9x 10.3x
EV / FCF 65.2x -39.1x 93.5x -222x -807x 112x 130x 187x
FCF Yield 1.53% -2.56% 1.07% -0.45% -0.12% -4.85% 0.77% 0.53%
Dividend per Share 2 35 40 50 60 70 82 84.25 89.11
Rate of return 0.46% 0.66% 0.75% 0.95% 0.79% 1.36% 1.32% 1.4%
EPS 2 342.9 292.4 300.5 308.6 390.9 404.3 407 431.9
Distribution rate 10.2% 13.7% 16.6% 19.4% 17.9% 20.3% 20.7% 20.6%
Net sales 1 7,26,424 7,55,414 8,27,697 9,64,989 10,11,390 10,99,583 11,89,220 12,71,634
EBITDA 1 46,932 44,906 47,496 51,425 62,633 66,929 69,780 74,418
EBIT 1 33,147 29,796 30,128 31,501 40,404 42,353 44,022 46,543
Net income 1 27,156 23,155 23,797 24,454 30,978 32,046 32,271 34,240
Net Debt 1 -49,534 -32,975 -27,727 -24,972 -7,081 -20,280 -25,601 -28,329
Reference price 2 7,615.00 6,100.00 6,630.00 6,345.00 8,832.00 6,383.00 6,383.00 6,383.00
Nbr of stocks (in thousands) 79,198 79,198 79,198 79,258 79,257 79,257 - -
Announcement Date 12/07/21 11/07/22 10/07/23 12/07/24 11/07/25 13/07/26 - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
15.87x0.44x7.32x1.19% 317.46Cr
24.08x0.4x6.31x2.01% 689.49Cr
15.72x0.45x6.51x1.34% 320.54Cr
13.09x0.46x5.73x3.66% 277.49Cr
21.24x0.8x11.24x1.42% 239.56Cr
15.04x0.44x4.23x3.37% 143.92Cr
17.46x0.51x6.97x4.09% 36Cr
Average 17.50x 0.50x 6.90x 2.44% 289.25Cr
Weighted average by Cap. 18.87x 0.48x 6.87x 2.06%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 3349 Stock
  4. Valuation COSMOS Pharmaceutical Corporation